Drug-Eluting Stents Not Cost-Effective In All Patients

If used in all patients, drug-eluting stents are not good value for money, even if prices were to be substantially reduced. However they are cost-effective in a subset of high-risk patients. These are the conclusions of authors of an Article in this week’s edition of The Lancet. [click link for full article]

More: continued here

Filed under: Cardiovascular on November 2nd, 2007